Cargando…
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
The anecdotal reports of promising results seen with immunotherapy and radiation in advanced malignancies have prompted several trials combining immunotherapy and radiation. However, the ideal timing of immunotherapy with radiation has not been clarified. Tumor bearing mice were treated with 20Gy ra...
Autores principales: | Young, Kristina H., Baird, Jason R., Savage, Talicia, Cottam, Benjamin, Friedman, David, Bambina, Shelly, Messenheimer, David J., Fox, Bernard, Newell, Pippa, Bahjat, Keith S., Gough, Michael J., Crittenden, Marka R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900555/ https://www.ncbi.nlm.nih.gov/pubmed/27281029 http://dx.doi.org/10.1371/journal.pone.0157164 |
Ejemplares similares
-
The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor
por: Crittenden, Marka R., et al.
Publicado: (2013) -
Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
por: Crittenden, Marka R., et al.
Publicado: (2012) -
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
por: Crittenden, Marka R., et al.
Publicado: (2016) -
Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
por: Friedman, David J, et al.
Publicado: (2014) -
Immune consequences of CT-guided radiation therapy of mouse mammary tumors
por: Gough, Michael J, et al.
Publicado: (2013)